---

Alan Waterhouse Named President Of Pci Services

Waterhouse Succeeds Daniel F. Gerner, Who Retires After 35 Years Distinguished by Industry-Leading Growth

DUBLIN, Ohio August 24, 2000 - Cardinal Health, Inc. (NYSE: CAH), a leading provider of products and services supporting the health-care industry, announced today it has named Alan Waterhouse, 41, as president of PCI Services, its Philadelphia-based packaging subsidiary. PCI is the world's largest fully integrated contract packager for pharmaceuticals, operating 15 facilities worldwide. Waterhouse replaces Daniel F. Gerner, who is retiring after more than 35 years with PCI.

"Dan's leadership of PCI and his commitment to customers helped build an outstanding organization," said John C. Kane, vice chairman, president and chief operating officer of Cardinal Health. "During his tenure as president of PCI, the company has grown exponentially by focusing on the packaging needs of pharmaceutical companies."

Waterhouse joins PCI from Pyxis Corporation (San Diego), another Cardinal Health company, where he was vice president, Manufacturing/Operations, responsible for production, materials management, worldwide logistics, property and facilities management and information technology. Before joining Pyxis five years ago, Waterhouse held several senior management positions in manufacturing and operations with General Motors Corporation.

"We are pleased to have identified a strong internal candidate in Al," Kane said. "He brings extensive experience in the manufacturing services area, which is essential as we continue to expand the capacity and capabilities of PCI Services. His expertise will be extremely valuable as we broaden Cardinal's offering of services for our pharmaceutical company customers."

Waterhouse holds a bachelor's degree from Otterbein College in Westerville, Ohio and a master's in business administration from Xavier University in Cincinnati.

Philadelphia-based PCI offers blister packaging, bottle-filling and pouch packaging, thermo-forming, custom hand assembly, liquid and powder packaging, hospital unit dose packaging, specialized packaging for clinical trials, folding cartons, printed inserts/outserts and labels, tamper-evident and child-resistant packaging, and analytical-testing services for pharmaceuticals and biotechnology products. PCI is part of a growing family of Cardinal companies whose services help pharmaceutical and biotechnology companies formulate, develop, produce, package, launch, distribute and market products.

Cardinal Health, Inc. (http://www.cardinal.com) is a leading provider of products and services supporting the health-care industry. Cardinal companies develop, manufacture, package and market products for patient care; develop drug-delivery technologies; distribute pharmaceuticals, medical-surgical and laboratory supplies; and offer consulting and other services that improve quality and efficiency in health care. The company employs more than 40,000 people on five continents and produces annual revenues of more than $25 billion.

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to) the costs and difficulties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships, changes in the distribution outsourcing pattern for health-care products and/or services, and the costs and other effects of governmental regulation and legal and administrative proceedings. Cardinal undertakes no obligation to update or revise any forward-looking statements.

Home | Sitemap | Legal | Privacy policy